tiprankstipranks
Arbutus Biopharma Corporation (ABUS)
NASDAQ:ABUS
US Market

Arbutus Biopharma (ABUS) Stock Investors

Compare
1,236 Followers
Based on 793,836 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ABUS
On average, investors allocate 0.00% of their portfolios to ABUS
The average holding size of this company in investors' portfolios.

Investor Sentiment

Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 793,836 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ABUS

0.8%
Last 7
Days
2.4%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ABUS, out of 793,836 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ABUS Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.00%
$3.44
Based on the activity of investors who made their portfolios public
The table shows changes in ABUS in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ABUS Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Nio
8.87%
-0.78%
-0.55%
8.06B
Consumer Cyclical
Lucid Group
5.41%
-0.71%
+0.35%
7.03B
Consumer Cyclical
Viking Therapeutics
3.84%
-0.65%
-2.64%
2.88B
Healthcare
Riot Platforms
4.54%
-0.92%
-1.31%
2.60B
Financial
Marathon Digital Holdings
4.96%
-0.73%
-0.15%
4.31B
Financial
Block
3.60%
-0.22%
+3.65%
34.28B
Technology
Ford Motor
5.67%
-0.72%
-0.06%
38.52B
Consumer Cyclical
Delta Air Lines
4.73%
-0.74%
+3.46%
28.32B
Industrials
Bristol Myers
3.59%
-0.65%
-0.74%
122.13B
Healthcare
CVS Health
4.37%
-1.14%
-1.49%
84.65B
Healthcare
Based on the activity of 793,836 active portfolios
Open your Smart Portfolio

ABUS Investor Analysis

ABUS investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
8.1%
of ABUS holders
are under 35
Average Segment Performance
Average P/E Ratio17.86
Beta11.00
Dividend Yield3.91%
ABUS investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
53.7%
of ABUS holders
are between 35–55
Average Segment Performance
Average P/E Ratio16.98
Beta19.48
Dividend Yield3.42%
ABUS investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
38.2%
of ABUS holders
are over 55
Average Segment Performance
Average P/E Ratio13.92
Beta12.14
Dividend Yield3.66%
Overview of age group and performance of ABUS stock investors
See who invests in ABUS according to age group and performance.

FAQ

How many retail Investors hold ABUS?
<0.1% of TipRanks' retail investors hold ABUS in their portfolios.
    What is ABUS Investor Sentiment?
    ABUS’s Investor Sentiment is Negative.
      What percentage of retail investors changed their holding of ABUS in the last 7 days?
      ▲ 0.8% of TipRanks' retail investors changed their holding of ABUS in the last 7 days.
        What percentage of retail investors changed their holding of ABUS in the last 30 days?
        ▼ 2.4% of TipRanks' retail investors changed their holding of ABUS in the last 30 days.
          What is the average age of retail investors who hold ABUS?
          The average age of ABUS Holders is between 35–55.
            What other stocks have ABUS investors also bought?
            ABUS Investors also bought NIO, LCID, VKTX, RIOT, MARA, XYZ, F, DAL, BMY, CVS.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALGNAlign Tech
              ALKSAlkermes
              CORCencora
              AZNAstraZeneca
              BDXBecton Dickinson
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis